Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc gained 1.180% today.
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
As a result the target price of 184 € shows a very positive potential of 77.86% compared to the current price of 103.45 € for Jazz Pharmaceuticals plc.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals plc | 1.180% | -0.337% | -3.767% | -18.254% | -7.261% | -27.909% | -12.331% |
Opko Health Inc. | -0.070% | 5.305% | -2.952% | -8.032% | -14.189% | -60.895% | -41.771% |
Catalent Inc. | 0.340% | 0.459% | 0.401% | 21.246% | 27.573% | -40.610% | 26.957% |
Repligen Corp. | -0.100% | 0.678% | -2.225% | 9.244% | -6.921% | 1.102% | - |
Comments
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $230.00 to $200.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $222.00 price target on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat